This is a non-core endpoint: only basic statistics are computed.
In situ neoplasms (controls excluding all cancers)
CD2_INSITU_EXALLC
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
2 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints
-
Remove individuals based on genotype QC
11471
CD2_INSITU_EXALLC
Control definitions
Control exclude
C3_CANCER
Extra metadata
Level in the ICD hierarchy
1
First used in FinnGen datafreeze
DF6
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
In situ neoplasms (controls excluding all cancers)
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11471 | 7879 | 3592 |
| Unadjusted prevalence (%) | 2.78 | 3.42 | 1.98 |
| Mean age at first event (years) | 61.27 | 56.05 | 72.72 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_INSITU_EXALLC – In situ neoplasms (controls excluding all cancers)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after In situ neoplasms (controls excluding all cancers)
↥Endpoint not on priority list, no data to show.